ELOX · Forms 3, 4, 5
Insider trades at Eloxx Pharmaceuticals, Inc.
No open-market insider buys or sells at Eloxx Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Eloxx Pharmaceuticals, Inc. (ELOX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Eloxx Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Domicilium Real Estate Fund III LP | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Domicilium Real Estate Fund III LP | 10% owner | Other | 238,422 | Form 4 | |||
| Domicilium Real Estate Fund III LP | 10% owner | Other | 361,578 | Form 4 | |||
| Stephen W Webster | Director | Options or other derivatives | Form 4 | ||||
| Alan Edmund Walts | Director | Options or other derivatives | Form 4 | ||||
| Nina S Kjellson | Director | Options or other derivatives | Form 4 | ||||
| Sumit Aggarwal | President and CEO | Options or other derivatives | Form 4 | ||||
| Steven D Rubin | Director | Options or other derivatives | Form 4 | ||||
| Stephen W Webster | Director | Became an insider (Form 3) | Form 3 | ||||
| Nina S Kjellson | Director | Became an insider (Form 3) | Form 3 | ||||
| Domicilium Real Estate Fund III LP | 10% owner | Other | 113,636 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.